Abstract: The present disclosure provides, inter alia, methods for treating cancers including leukemia using low doses of an anthracycline such as doxorubicin.

Abstract: Provided herein is technology relating to a function allocation system (FAS) that deploys artificial intelligence models for a connected automated highway (CAH) system and a connected automated vehicle (CAV) system to distribute driving intelligence between the CAV system and the CAH system. The FAS comprises a communication module, a data module, and a computing module. The computing module is configured to analyse scenes using sensing data, determine automated driving function requirements, deploy function allocation methods, and analyse CAH system and CAV system functions. The function allocation methods provide analysis, guidance, and optimization capabilities for sensing, decision-making, and control functions. The FAS allocates automated driving functions to the CAV system and the CAH system based on their respective intelligence levels.

Abstract: Provided herein is an artificial intelligence-based mobile roadside intelligent unit (MRIU) for providing, supplementing, and/or enhancing the control and operation of autonomous vehicles in normal and long-tail scenarios. The MRIU comprises a computing module configured to provide supplemental computation capability for autonomous driving. The MRIU comprises a communication module to communicate and exchange data with a vehicle or a cloud. The MRIU provides prediction, decision-making, and/or control functions for autonomous driving. The MRIU provides edge computing capability for autonomous vehicles to train and operate artificial intelligence-based intelligent driving models in a distributed fashion. Specifically, an edge computing unit conducts data fusion and data feature extraction, provides prediction, formulates control strategies, generates vehicle control instructions, and/or distributes vehicle control information and/or instructions for an autonomous vehicle.

Abstract: This technology relates to autonomous vehicle (AV) control systems tailored for critical points of a partially instrumented infrastructure. The first system integrates an onboard unit (OBU) and communication modules to interact with roadside units (RSUs) or a cloud platform, delivering time-sensitive control instructions to vehicles at critical points. The OBUs execute these instructions for driving tasks. The second system combines an OBU with a cloud platform, leveraging cloud services for enhanced functionality like storage and computing. It adapts to diverse critical point scenarios, employing proactive incident prediction and rapid detection methods for optimized performance.

Abstract: Provided herein is technology relating to intelligent transportation systems and automated vehicles and particularly, but not exclusively, to function allocation systems and methods for a connected automated vehicle highway system that provides transportation management and operations and vehicle control for connected and automated vehicles.

Abstract: Provided herein is technology relating to automated driving and particularly, but not exclusively, to a mobile intelligent road infrastructure technology configured to serve automated driving systems by providing, supplementing, and/or enhancing autonomous driving functions for connected automated vehicles under common and unusual driving scenarios.

Abstract: Provided herein is technology relating to automated driving and particularly, but not exclusively, to a mobile intelligent road infrastructure technology configured to serve automated driving systems by providing, supplementing, and/or enhancing autonomous driving functions for connected automated vehicles under common and unusual driving scenarios.

Abstract: The technology relates to a systematic intelligent system (SIS) configured to share data and allocate computing resources among automated driving systems (ADS), e.g., using unified data specifications and interfaces. The SIS comprises systematic intelligent units (STU) that serve components of ADS, including vehicle intelligent units (VIU) and roadside intelligent units (RIU), and is configured to perform methods to serve an entire trip.

Abstract: Provided herein is technology relating to intelligent transportation systems and automated vehicles and particularly, but not exclusively, to function allocation systems and methods for a connected automated vehicle highway system that provides transportation management and operations and vehicle control for connected and automated vehicles.

Abstract: The disclosure provides methods of treating cancer by selectively inhibiting p-S552-?-catenin, p-T217-?-catenin, p-T332-?-catenin, and/or p-S675-?-catenin production and/or activity. Such methods also and/or limit cancer-initiating cells.

Abstract: The present disclosure provides, inter alia, methods for treating cancers including leukemia using low doses of an anthracycline such as doxorubicin.

Abstract: The present invention relates to methods for expanding a stem cell population, as well as other cell populations. More particularly, the invention relates, inter alia, to methods and compositions for expanding a stem cell and/or other cell population, particularly a hematopoietic stem cell population.

Abstract: The present invention relates to methods and kits for expanding a stem cell population. More particularly, the invention relates, inter alia, to methods, kits, and compositions for expanding a stem cell population, particularly a hematopoietic stem cell population.

Abstract: The present invention relates to methods for expanding a stem cell population. More particularly, the invention relates, inter alia, to methods and compositions for expanding a stem cell population, particularly a hematopoietic stem cell population.

Abstract: Methods and kits for expanding a stem cell population, particularly a hematopoietic stem cell population, in the presence of a DNA methyltransferase modulator and a Wnt pathway modulator are disclosed.

Abstract: The present invention relates to methods for expanding a stem cell population. More particularly, the invention relates, inter alia, to methods and compositions for expanding a stem cell population, particularly a hematopoietic stem cell population.

Abstract: The present invention relates to methods and kits for expanding a stem cell population. More particularly, the invention relates, inter alia, to methods, kits, and compositions for expanding a stem cell population, particularly a hematopoietic stem cell population.

Abstract: The present invention relates to a purified molecules, including antibodies, that bind specifically to murine ?-catenin phosphorylated at amino acid position Serine552 and to orthologs thereof, such as mammalian orthologs, including human orthologs. Methods of making and using such purified molecules are also provided. Kits containing such purified molecules are further provided.

Abstract: The present invention relates to methods and kits for expanding a stem cell population. More particularly, the invention relates, inter alia, to methods, kits, and compositions for expanding a stem cell population, particularly a hematopoietic stem cell population.

Abstract: Methods and kits for expanding a stem cell population, particularly a hematopoietic stem cell population, in the presence of a DNA methyltransferase modulator and a Wnt pathway modulator are disclosed.